Simpson Thacher Represents Underwriters in the US$350.8 Million Registered Follow-on Offering of American Depositary Shares by AU Optronics Corp.

The Hong Kong office of the Firm represented the underwriters in the US$350.8 million registered follow-on offering of 79,719,958 American Depositary Shares by AU Optronics Corp. (“AUO”). Citigroup Global Markets acted as the Global Coordinator for the offering, and Citigroup Global Markets and UBS AG acted as joint bookrunners for the offering. ANZ, ING Bank, Mizuho Securities and Standard Chartered Securities acted as the Co-Managers of the offering.

More >>

Tags:  Simpson Thacher & Bartlett LLP | Hong Kong

Mayer Brown Represents Wepa Hygieneprodukte GmbH on its inaugural €275 Million High Yield Bond Offering

Leading global law firm Mayer Brown represented Wepa Hygieneprodukte GmbH, a leading, family-owned producer and supplier of tissue products in Europe, on the inaugural offering of €275 million of its 6.500% Senior Secured Notes due 2020 and on a new €90 million Senior Revolving Credit Facility. The notes were listed on the Luxembourg Stock Exchange. The proceeds of the offering, which closed on 13 May 2013, together with drawings under the Senior Revolving Credit Facility, will be used primarily to refinance existing indebtedness.

More >>

Tags:  Mayer Brown LLP

Sidley Austin LLP Continues to Expand in Houston with the Hiring of Capital Markets Partner Tim Langenkamp

Sidley Austin LLP announced today that Timothy C. Langenkamp, a capital markets lawyer with extensive experience in energy transactions, has joined the firm as a partner. He is resident in the firm’s Houston office and a member of its Securities/Capital Markets practice group. This addition continues the expansion of Sidley’s Houston office and further enhances the firm’s energy-focused capital markets team.

More >>

Tags:  Sidley Austin LLP | Houston

Jenner & Block Represents Obagi Medical Products in Acquisition by Valeant

On April 25, a Jenner & Block team representing Obagi Medical Products closed a $441 million cash tender offer for Obagi by Montreal-based Valeant Pharmaceuticals International, Inc. Obagi is a California-based specialty pharmaceutical company that develops, markets and is a leading provider of proprietary topical aesthetic and therapeutic prescription-strength skin care systems in the physician-dispensed market.

More >>

Tags:  Jenner & Block, LLP